DavidAWaltzMD

Pediatric Asthma Pulmonology

Assistant Clinical Professor of Pediatrics, Boston Children's Hospital

Dr. Waltz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
300 Longwood Ave
Boston, MA 02115
Phone+1 617-355-1900

Fax+1 617-730-0084

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Pulmonology, 1988 - 1991
University of RochesterResidency, Pediatrics, 1985 - 1988
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1985

PubMed

1080 citations
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
Peter G. Middleton, Marcus A. Mall, Pavel Dřevínek, Larry C. Lands, Edward F. McKone
The New England Journal of Medicine. 2019-10-31
682 citations
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation : a double...
Harry G.M. Heijerman, Edward F. McKone, Damian G. Downey, Eva Van Braeckel, Steven M. Rowe
Lancet. 2019-11-23
65 citations
Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del‐CFTR
Steven M. Rowe, Susanna A. McColley, Ernst Rietschel, Xiaolei Li, Scott C. Bell
Annals of the American Thoracic Society. 2017-02-01

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 28-Day Study Of DenNational Center For Research Resources2006
Duration Of Antimicrobial Treatment Effect Following Administration Of Tobi SoluNational Center For Research Resources2005
A Phase 2 Randomized Double Blind Parallel Dose Ranging Study Of Oral Theraclec-National Center For Research Resources2005
24 Weeks Of Oral Treatment With Biil 284 Bs In Adult And Pediatric CFNational Center For Research Resources2005
A Multi-Center, Dbl-Blind, Randomized, Placebo-Controlled, 28-Day Study Of Ins37National Center For Research Resources2004–2005
Duration/Effect Antimicrobial Tx Following Tobramycin InNational Center For Research Resources2004
A Randomized, Db-Blind, Placebo-Controlled Study To Investigate The Efficacy OfNational Center For Research Resources2004
A Phase IA Study Of Multiple Ascending Doses Of Nacystelyn In CF PatientsNational Center For Research Resources2004
Inhaled Ib-367 In Adults With Cystic FibrosisNational Center For Research Resources2000–2002
Urokinase--A Link Between Cell Adhesion And ProteolysisNational Heart, Lung, And Blood Institute1994–1998